Fiber One introduces nutty clusters and almonds cereal
MINNEAPOLIS — Fiber One has introduced a cereal that touts fiber, crunchy nut clusters, real almond slices and whole grain flakes.
Fiber One nutty clusters and almonds cereal, now available at retailers nationwide, touts 180 calories per serving, as well as 43% of the recommended daily value of fiber in each serving.
"Cereal is a great breakfast choice, and Fiber One is excited about this delicious and nutritious addition to our family," Fiber One VP Thierry Ibri said. "The perfect combination of crunch and sweetness, Fiber One nutty clusters and almonds cereal is a fiber-filled way to start your morning."
The new cereal carries an average retail price of $4.39 per box.
FDA approves overactive bladder drug made by Astellas
SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating overactive bladder made by Astellas Pharma, the agency said Thursday.
The FDA announced the approval of Myrbetriq (mirabegron), which works by relaxing the bladder muscle while the organ is filling. In patients with overactive bladder, the muscle can’t be controlled, squeezes too often or squeezes without warning. Symptoms of overactive bladder include the need to urinate too often, the need to urinate immediately and incontinence. The condition affects about 33 million Americans.
The FDA’s approval of the drug was based on a clinical trial of 4,116 patients who were randomly assigned to take Myrbetriq at 25 mg, 50 mg, 100 mg or placebo each day for 12 weeks.
Purdue Pharma, National Education Association team up to combat Rx drug abuse
WASHINGTON — A drug maker and a branch of the National Education Association have released a set of education resources designed to curb prescription drug abuse and misuse.
The NEA Health Information Network and Purdue Pharma announced Thursday the release of "Rx for Understanding," which includes 10 cross-curricular lessons for middle school students. The lessons are aligned with the National Health Education Standards and the Common Core State Standards.
"We know that 20% of high school students have reported that they have taken a prescription drug without a doctor’s prescription," NEA HIN executive director Jerry Newberry said. "This behavior endangers student health and can interfere with academic success. NEA HIN welcomes our partnership with Purdue Pharma to help teachers inform students about the risks in misusing prescription medication."